Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Friedman

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Science (New York, N.Y.)|June 3, 1988
Retirement policyL M Friedman
Circulation|December 1, 1980
Summary of design features: clinical trials of platelet-active drugs in cerebrovascular diseaseL M Friedman
European Heart Journal|September 1, 1984
Can chronic antidysrhythmic treatment prevent sudden death?L M Friedman
Circulation|June 1, 1983
How do the various beta blockers compare in type, frequency and severity of their adverse effects?L M Friedman
Controlled Clinical Trials|December 1, 1984
Issues in medication adherence assessment in clinical trials of the National Heart, Lung, and Blood InstituteM E Mattson, L M Friedman
The American Journal of Cardiology|August 15, 1994
Relative role of meta-analysis and randomized controlled trials in the assessment of medical therapiesM J Domanski, L M Friedman
American Journal of Epidemiology|April 1, 1985
Assessment of angina pectoris after myocardial infarction: comparison of "Rose Questionnaire" with physician judgment in the Beta-Blocker Heart Attack TrialL M Friedman, R P Byington
Geriatric Nursing (New York, N.Y.)|July 1, 1990
Cardiovascular options for the 1990sE B Schron, L M Friedman
Journal of Cardiovascular Pharmacology|January 1, 1992
Statistical problems in the design of antiarrhythmic drug trialsL M Friedman, E B Schron
The New England Journal of Medicine|October 7, 1982
Community hospitals in clinical trialsL M Friedman, C D Furberg
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Science (New York, N.Y.)|June 3, 1988
Retirement policyL M Friedman
Circulation|December 1, 1980
Summary of design features: clinical trials of platelet-active drugs in cerebrovascular diseaseL M Friedman
European Heart Journal|September 1, 1984
Can chronic antidysrhythmic treatment prevent sudden death?L M Friedman
Circulation|June 1, 1983
How do the various beta blockers compare in type, frequency and severity of their adverse effects?L M Friedman
Controlled Clinical Trials|December 1, 1984
Issues in medication adherence assessment in clinical trials of the National Heart, Lung, and Blood InstituteM E Mattson, L M Friedman
The American Journal of Cardiology|August 15, 1994
Relative role of meta-analysis and randomized controlled trials in the assessment of medical therapiesM J Domanski, L M Friedman
American Journal of Epidemiology|April 1, 1985
Assessment of angina pectoris after myocardial infarction: comparison of "Rose Questionnaire" with physician judgment in the Beta-Blocker Heart Attack TrialL M Friedman, R P Byington
Geriatric Nursing (New York, N.Y.)|July 1, 1990
Cardiovascular options for the 1990sE B Schron, L M Friedman
Journal of Cardiovascular Pharmacology|January 1, 1992
Statistical problems in the design of antiarrhythmic drug trialsL M Friedman, E B Schron
The New England Journal of Medicine|October 7, 1982
Community hospitals in clinical trialsL M Friedman, C D Furberg
Pageof 4